Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Takeda
Company Monitoring Page for Takeda
latest headlines for company on cafepharma
Takeda touts positive first-line leukemia results — but isn't quite ready to reveal the hard data
Endpoints
Thu, 11/17/22 - 11:36 pm
Tags:
Takeda
,
Ariad Pharmaceuticals
,
Iclusig
,
clinical trials
,
acute lymphoblastic leukemia
Seagen's highest selling drug snags a label expansion for pediatric cancer patients
Endpoints
Sun, 11/13/22 - 07:01 pm
Tags:
Seagen
,
Takeda
,
Adcetris
,
Hodgkin's lymphoma
,
FDA
,
pediatric
If at first... pharma’s most drawn-out development timelines revealed
EP Vantage
Thu, 11/3/22 - 10:54 am
Tags:
Kyowa Kirin
,
Takeda
,
Eiger BioPharmaceuticals
,
AstraZeneca
,
Teva Pharmaceutical
,
Bavarian Nordic
,
Halozyme
,
Novartis
,
MannKind
,
drug development
Takeda sues Apotex over prospective generic versions of its top leukemia drug
Endpoints
Thu, 10/20/22 - 11:33 pm
Tags:
Takeda
,
Iclusig
,
generics
,
Apotex
Takeda adds one more late-stage treatment to its growing roster of celiac drugs
Endpoints
Thu, 10/20/22 - 10:39 am
Tags:
Takeda
,
celiac disease
,
ZED1227
,
TAK-227
,
Zedira
Few safe havens surface in another down quarter for biopharma
EP Vantage
Fri, 10/14/22 - 10:03 am
Tags:
biopharma stocks
,
COVID-19
,
Eli Lilly
,
Bristol Myers Squibb
,
Merck
,
Daiichi Sankyo
,
Vertex Pharmaceuticals
,
Takeda
,
Neurocrine
,
Sarepta Therapeutics
,
Orion
,
Pfizer
,
GSK
,
Roche
,
Moderna Therapeutics
,
BeiGene
,
BioNTech
,
Novavax
,
CureVac
Takeda to stop making parathyroid drug Natpara in 2024 after production challenges
BioPharma Dive
Tue, 10/4/22 - 11:40 pm
Tags:
Takeda
,
Natpara
,
drug manufacturing
,
hypoparathyroidism
Biotech’s near-term key catalysts
EP Vantage
Thu, 09/29/22 - 09:45 am
Tags:
Biogen
,
Eisai
,
Alzheimer's disease
,
Arrowhead Pharmaceuticals
,
Takeda
,
RNAi
,
Madrigal
,
NASH
,
Ascendis
,
FDA
MHRA raises concerns with switching between long-acting J&J, Novartis and Takeda ADHD drugs
Fierce Pharma
Tue, 09/27/22 - 10:37 am
Tags:
Takeda
,
JNJ
,
Novartis
,
ADHD
,
MHRA
,
Concerta XL
,
Ritalin XL
,
Equasym XL
Puma pounces on failed Takeda drug, snapping up cancer prospect for knockdown price
Fierce Biotech
Wed, 09/21/22 - 10:17 am
Tags:
Puma Biotechnology
,
Takeda
,
Aurora A/angiogenic kinase inhibitor
,
clinical trials
,
Alisertib
Takeda’s manufacturing site in Belgium gets a €300M boost for plasma therapy production
Endpoints
Wed, 09/14/22 - 07:54 pm
Tags:
Takeda
,
R&D
,
drug manufacturing
,
Belgium
,
Plasma Therapeutics
One week after Takeda walked away, Finch faces second round of layoffs, pipeline pruning
Endpoints
Thu, 09/1/22 - 10:45 am
Tags:
Finch Therapeutics
,
Takeda
,
layoffs
,
C. difficile
Finch Therapeutics Regains Rights to Two Takeda-Owned IBD Drugs
BioSpace
Fri, 08/26/22 - 10:41 am
Tags:
Takeda
,
Finch Therapeutics
,
FIN-524
,
FIN-525
,
inflammatory bowel disease
Revealed: which pharma companies leading the way in artificial intelligence
Clinical Trials Arena
Fri, 08/26/22 - 10:37 am
Tags:
artificial intelligence
,
Pfizer
,
Novartis
,
AstraZeneca
,
Johnson & Johnson
,
Bristol Myers Squibb
,
Takeda
,
GSK
,
Bayer
,
Astellas
Years after Sanofi's Dengvaxia fiasco, Takeda lands first OK for its own dengue vaccine
Endpoints
Tue, 08/23/22 - 10:27 am
Tags:
Takeda
,
dengue
,
vaccines
,
WHO
,
TAK-003
,
Qdenga
,
Indonesia
Flush with $126M raise, Tessa Therapeutics woos new CEO from Takeda
Endpoints
Mon, 08/22/22 - 10:04 am
Tags:
Tessa Therapeutics
,
Takeda
,
Thomas Willemsen
,
CAR-T
,
Pharma CEOs
Takeda cuts ties to cancer drug landed in $120M Turnstone deal
Fierce Biotech
Thu, 07/28/22 - 10:59 am
Tags:
Takeda
,
narcolepsy
,
TAK-994
,
TAK-605
,
Turnstone Biologics
A year after netting Takeda partnership, small molecule startup arms itself with some new cash
Endpoints
Wed, 07/27/22 - 10:52 am
Tags:
startups
,
BridGene Biosciences
,
Takeda
,
funding
,
Eli Lilly
Ascletis, Takeda, Arrowhead & More Present New Findings at EASL Liver Conference
BioSpace
Tue, 06/28/22 - 10:49 am
Tags:
EASL
,
liver disease
,
Ascletis
,
Takeda
,
Arrowhead Pharmaceuticals
Takeda to further cement presence in Cambridge, MA biopharma hub with 600,000-square-foot R&D center
Endpoints
Wed, 06/22/22 - 10:30 am
Tags:
Takeda
,
biotech hubs
,
Cambridge MA
,
R&D
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.